Yea Italians seem to be the leaders when it comes to pegasys use in genotype D....
they are very pro sequential peginterferon add on since they studied hbsag quant among the first ones in the world and response of add on.
they have high cure rates by using these strategies of sequential add on despite we have almost all genotype D in italy which has the poorest clearance rates
i dont know there is a lot of hidden marketing strategies forcing all doctors but as most updated doctors they do know tdf is slightly more potent
Thx Steff.
What is the stance of pisa researchers on tenofovir and entecavir?
at first they were about to stop the development of the drug but then choose to use on humans since lung cancer happened only on rats and not monkeys
the drug was approved with special monitoring for cancer, the bad point is cancer can take decades to develop to detectable.....so i never liked etv and when i found it didnt work on my hbsag reduction but increased it and wasn t even able to fully suppress hbvdna to less than 20iu/ml i switched to combo and then tdf mono
studyforhope also mentioned that mitocondrial damage after decades of use is worst on etv so definitely a drug which is best for those with kidneys damage